Perioperative Intranasal Mupirocin for the Prevention of Surgical-Site Infections: Systematic Review of the Literature and Meta-Analysis
Infection Control and Hospital Epidemiology2005Vol. 26(12), pp. 916–922
Citations Over TimeTop 10% of 2005 papers
Abstract
Perioperative intranasal mupirocin appears to decrease the incidence of surgical-site infection when used as prophylaxis in nongeneral surgery. Given its low risk and low cost, use of perioperative intranasal mupirocin should be considered in these settings.
Related Papers
- → Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA(2015)185 cited
- → Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects(2009)179 cited
- → Prevention of Surgical Site Infections: Decontamination With Mupirocin Based on Preoperative Screening forStaphylococcus aureusCarriers or Universal Decontamination?(2015)58 cited
- → Mupirocin susceptibility of staphylococci 2022: Is it time for a change in MRSA decolonization protocols?(2022)15 cited
- → High prevalence of mupirocin resistance in methicillin resistant staphylococci and its clinical significance(2018)1 cited